Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Flaxman, Amy L"'
Autor:
Mentzer, Alexander J., O’connor, Daniel, Bibi, Sagida, Chelysheva, Irina, Clutterbuck, Elizabeth A., Demissie, Tesfaye, Dinesh, Tanya, Edwards, Nick J., Felle, Sally, Feng, Shuo, Flaxman, Amy L., Karp-tatham, Eleanor, Li, Grace, Liu, Xinxue, Marchevsky, Natalie, Godfrey, Leila, Makinson, Rebecca, Bull, Maireid B., Fowler, Jamie, Alamad, Bana, Malinauskas, Tomas, Chong, Amanda Y., Sanders, Katherine, Shaw, Robert H., Voysey, Merryn, Cavey, Ana, Minassian, Angela, Stuart, Arabella, Khozoee, Baktash, Hanumunthadu, Brama, Angus, Brian, Smith, Catherine C., Turnbull, Iain, Kwok, Jonathan, Emary, Katherine R. W., Cifuentes, Liliana, Ramasamy, Maheshi N., Cicconi, Paola, Finn, Adam, Mcgregor, Alastair C., Collins, Andrea M., Smith, Andrew, Goodman, Anna L., Green, Christopher A., Duncan, Christopher J. A., Williams, Christopher J. A., Ferreira, Daniela M., Turner, David P. J., Thomson, Emma C., Faust, Saul N.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine immunogenicity varies between individuals, and immune responses correlate with vaccine efficacy. Using data from 1,076 participants enrolled in ChAdOx1 nCov-19 vaccine efficacy tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c705819941159f2ce1aa834ccf01e370
https://ora.ox.ac.uk/objects/uuid:af446976-403c-43f6-aa84-ab8d4823a002
https://ora.ox.ac.uk/objects/uuid:af446976-403c-43f6-aa84-ab8d4823a002
Autor:
Emary, Katherine RW, Golubchik, Tanya, Aley, Parvinder K, Ariani, Cristina V, Angus, Brian, Bibi, Sagida, Blane, Beth, Bonsall, David, Cicconi, Paola, Charlton, Sue, Clutterbuck, Elizabeth A, Collins, Andrea M, Cox, Tony, Darton, Thomas C, Dold, Christina, Douglas, Alexander D, Duncan, Christopher JA, Ewer, Katie J, Flaxman, Amy L, Faust, Saul N, Ferreir, Daniela M, Feng, Shuo, Finn, Adam, Folegatti, Pedro M, Fuskova, Michelle, Galiza, Eva, Goodman, Anna L, Green, Catherine M, Green, Christopher A, Greenland, Melanie, Hallis, Bassam, Heath, Paul T, Hay, Jodie, Hill, Helen C, Jenkin, Daniel, Kerridge, Simon, Lazarus, Rajeka, Libri, Vincenzo, Lillie, Patrick J, Ludden, Catherine, Marchevsky, Natalie G, Minassian, Angela M, McGregor, Alastair C, Mujadidi, Yama F, Phillips, Daniel J, Plested, Emma, Pollock, Katrina M, Robinson, Hannah, Smith, Andrew, Song, Rinn, Snape, Matthew D, Sutherland, Rebecca K, Thomson, Emma C, Toshner, Mark, Turner, David PJ, Vekemans, Johan, Villafana, Tonya L, Williams, Christopher J, Hill, Adrian VS, Lambe, Teresa, Gilbert, Sarah C, Voysey, Merryn, Ramasamy, Maheshi N, Pollard, Andrew J, Consortium, The COVID-19 Genomics UK, Project, The AMPHEUS, Group, The Oxford COVID-19 Vaccine Trial
A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the United Kingdom from November 2020. Here we report efficacy of the adenoviral vector vaccine, ChAdOx1 nCoV-19, against this variant.
COVID-19 Genomics
COVID-19 Genomics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3360959dbc170b036cee90bdf148f3eb
Autor:
Emary, Katherine RW, Golubchik, Tanya, Aley, Parvinder K, Ariani, Cristina V, Angus, Brian, Bibi, Sagida, Blane, Beth, Bonsall, David, Cicconi, Paola, Charlton, Sue, Clutterbuck, Elizabeth A, Collins, Andrea M, Cox, Tony, Darton, Thomas C, Dold, Christina, Douglas, Alexander D, Duncan, Christopher JA, Ewer, Katie J, Flaxman, Amy L, Faust, Saul N, Ferreira, Daniela M, Feng, Shuo, Finn, Adam, Folegatti, Pedro M, Fuskova, Michelle, Galiza, Eva, Goodman, Anna L, Green, Catherine M, Green, Christopher A, Greenland, Melanie, Hallis, Bassam, Heath, Paul T, Hay, Jodie, Hill, Helen C, Jenkin, Daniel, Kerridge, Simon, Lazarus, Rajeka, Libri, Vincenzo, Lillie, Patrick J, Ludden, Catherine, Marchevsky, Natalie G, Minassian, Angela M, McGregor, Alastair C, Mujadidi, Yama F, Phillips, Daniel J, Plested, Emma, Pollock, Katrina M, Robinson, Hannah, Smith, Andrew, Song, Rinn, Snape, Matthew D, Sutherland, Rebecca K, Thomson, Emma C, Toshner, Mark, Turner, David PJ, Vekemans, Johan, Villafana, Tonya L, Williams, Christopher J, Hill, Adrian VS, Lambe, Teresa, Gilbert, Sarah C, Voysey, Merryn, Ramasamy, Maheshi N, Pollard, Andrew J, COVID-19 Genomics UK Consortium, AMPHEUS Project, Oxford COVID-19 Vaccine Trial Group
BACKGROUND: A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the efficacy of the adenoviral vector vaccine, ChAdOx1 nCoV-19 (AZD1222), against this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c40c9e4ae4e9c5cf3883d824ea7f351
https://www.repository.cam.ac.uk/handle/1810/322058
https://www.repository.cam.ac.uk/handle/1810/322058
Autor:
Mentzer, Alexander J., O’Connor, Daniel, Bibi, Sagida, Chelysheva, Irina, Clutterbuck, Elizabeth A., Demissie, Tesfaye, Dinesh, Tanya, Edwards, Nick J., Felle, Sally, Feng, Shuo, Flaxman, Amy L., Karp-Tatham, Eleanor, Li, Grace, Liu, Xinxue, Marchevsky, Natalie, Godfrey, Leila, Makinson, Rebecca, Bull, Maireid B., Fowler, Jamie, Alamad, Bana, Malinauskas, Tomas, Chong, Amanda Y., Sanders, Katherine, Shaw, Robert H., Voysey, Merryn, Snape, Matthew D., Pollard, Andrew J., Lambe, Teresa, Knight, Julian C.
Publikováno v:
Nature Medicine; 20230101, Issue: Preprints p1-11, 11p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: maheshi.ramasamy@paediatrics.ox.ac.uk., Minassian AM; The Jenner Institute, University of Oxford, Oxford, UK., Ewer KJ; The Jenner Institute, University of Oxford, Oxford, UK., Flaxman AL; The Jenner Institute, University of Oxford, Oxford, UK., Folegatti PM; The Jenner Institute, University of Oxford, Oxford, UK., Owens DR; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Angus B; The Jenner Institute, University of Oxford, Oxford, UK., Babbage G; The Jenner Institute, University of Oxford, Oxford, UK., Belij-Rammerstorfer S; The Jenner Institute, University of Oxford, Oxford, UK., Berry L; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Bittaye M; The Jenner Institute, University of Oxford, Oxford, UK., Cathie K; Paediatric Medicine, University of Southampton, Southampton, UK., Chappell H; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Charlton S; National Infection Service, Public Health England, Porton Down, Salisbury, UK., Cicconi P; The Jenner Institute, University of Oxford, Oxford, UK., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Colin-Jones R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Fedosyuk S; The Jenner Institute, University of Oxford, Oxford, UK., Fuskova M; The Jenner Institute, University of Oxford, Oxford, UK., Gbesemete D; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Green C; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK., Hallis B; National Infection Service, Public Health England, Porton Down, Salisbury, UK., Hou MM; The Jenner Institute, University of Oxford, Oxford, UK., Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK., Joe CCD; The Jenner Institute, University of Oxford, Oxford, UK., Kelly EJ; AstraZeneca BioPharmaceuticals Research and Development, Washington, DC, USA., Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Lawrie AM; The Jenner Institute, University of Oxford, Oxford, UK., Lelliott A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Lwin MN; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Makinson R; The Jenner Institute, University of Oxford, Oxford, UK., Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Mujadidi Y; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Munro APS; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Pacurar M; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Rand J; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Rawlinson T; The Jenner Institute, University of Oxford, Oxford, UK., Rhead S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Robinson H; Nuffield Department of Medicine, and Oxford Centre for Clinical Tropical Medicine and Global Health, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Ritchie AJ; The Jenner Institute, University of Oxford, Oxford, UK., Ross-Russell AL; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Saich S; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Singh N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Smith CC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA., Tarrant R; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK., Themistocleous Y; The Jenner Institute, University of Oxford, Oxford, UK., Thomas KM; National Infection Service, Public Health England, Porton Down, Salisbury, UK., Villafana TL; AstraZeneca BioPharmaceuticals Research and Development, Bethesda, MA, USA., Warren SC; NIHR Clinical Research Facility, University Hospital Southampton NHS Trust, Southampton, UK., Watson MEE; The Jenner Institute, University of Oxford, Oxford, UK., Douglas AD; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Hill AVS; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Lambe T; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Gilbert SC; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Trust and Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Publikováno v:
Lancet (London, England) [Lancet] 2021 Dec 19; Vol. 396 (10267), pp. 1979-1993. Date of Electronic Publication: 2020 Nov 19.
Autor:
Emary KRW; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Golubchik T; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ariani CV; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Angus B; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Blane B; COVID-19 Genomics UK, Department of Medicine, University of Cambridge, Cambridge, UK., Bonsall D; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Cicconi P; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Charlton S; National Infection Service, Public Health England, Salisbury, UK., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Collins AM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Cox T; UK Biocentre, Milton Keynes, UK., Darton TC; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Douglas AD; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Duncan CJA; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Immunity and Inflammation Theme, Newcastle University, Newcastle upon Tyne, UK., Ewer KJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Flaxman AL; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Ferreira DM; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Feng S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Finn A; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Folegatti PM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Fuskova M; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Galiza E; St George's Vaccine Institute, St George's, University of London, London, UK., Goodman AL; Department of Infection, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK; MRC Clinical Trials Unit, University College London, London, UK., Green CM; Clinical BioManufacturing Facility, University of Oxford, Oxford, UK., Green CA; NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Hallis B; National Infection Service, Public Health England, Salisbury, UK., Heath PT; St George's Vaccine Institute, St George's, University of London, London, UK., Hay J; University of Glasgow, Glasgow, UK; Lighthouse Laboratory in Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Hill HC; Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Jenkin D; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Lazarus R; Severn Pathology, North Bristol NHS Trust, Bristol, UK., Libri V; NIHR UCLH Clinical Research Facility, London, UK; NIHR UCLH Biomedical Research Centre, London, UK., Lillie PJ; Hull University Teaching Hospitals NHS Trust, Hull, UK., Ludden C; COVID-19 Genomics UK, Department of Medicine, University of Cambridge, Cambridge, UK., Marchevsky NG; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Minassian AM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., McGregor AC; London Northwest University Healthcare, Harrow, UK., Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Phillips DJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Pollock KM; NIHR Imperial Clinical Research Facility, London, UK; NIHR Imperial Biomedical Research Centre, London, UK., Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Smith A; College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital and School, University of Glasgow, Glasgow, UK., Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Sutherland RK; Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK., Thomson EC; MRC University of Glasgow Centre for Virus Research, Glasgow, UK; Severn Pathology, North Bristol NHS Trust, Bristol, UK; Department of Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, UK., Toshner M; Heart Lung Research Institute, Department of Medicine, University of Cambridge, Cambridge, UK; NIHR Cambridge Clinical Research Facility, Cambridge, UK; Cambridge University Hospital and Royal Papworth NHS Foundation Trusts, Cambridge, UK., Turner DPJ; University of Nottingham, Nottingham, UK; Nottingham University Hospitals NHS Trust, Nottingham, UK., Vekemans J; AstraZeneca BioPharmaceuticals, Gaithersburg, MD, USA., Villafana TL; AstraZeneca BioPharmaceuticals, Gaithersburg, MD, USA., Williams CJ; Public Health Wales, Cardiff, UK; Aneurin Bevan University Health Board, Newport, UK., Hill AVS; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Gilbert SC; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: maheshi.ramasamy@paediatrics.ox.ac.uk., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Publikováno v:
Lancet (London, England) [Lancet] 2021 Apr 10; Vol. 397 (10282), pp. 1351-1362. Date of Electronic Publication: 2021 Mar 30.